Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Sarcoma 1

Conditions

Multiple Myeloma 2Back Pain 2Osteoporosis 1Neoplasms 1Bone Neoplasms 1Bone Diseases, Metabolic 1

Interventions

Dexamethasone 315Bortezomib 166Lenalidomide 132pomalidomide 113daratumumab 96carfilzomib 69Cyclophosphamide 44Calcium Dobesilate 41belantamab mafodotin 32elotuzumab 31fludarabine 27ixazomib 24isatuximab 21Melphalan 21venetoclax 18selinexor 17talquetamab 15Prednisone 15plerixafor 14Panobinostat 14Granulocyte Colony-Stimulating Factor 14Injections 12idecabtagene vicleucel 11Zoledronic Acid 11Thalidomide 11Azacitidine 11pembrolizumab 10tocilizumab 9nirogacestat 9liposomal doxorubicin 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Kyphoplasty × Plasma cell × Clear all
NCT00211211 2017-12-08

FREE Study - Fracture Reduction Evaluation

Medtronic Spinal and Biologics

Phase 4 Completed
300 enrolled
Plasma cellSarcoma

Back Pain, Bone Diseases, Metabolic, Bone Neoplasms, Multiple Myeloma, Osteoporosis

NCT01410929 2017-01-20

MM

Merit Medical Systems, Inc.

Phase 4 Withdrawn
Plasma cell

Back Pain, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡